← Back to headlines
New Cystic Fibrosis Therapy Seeks Refund Approval in Poland
Vertex Pharmaceuticals has applied for refund approval for its latest drug, a new targeted therapy for specific genetic subtypes of cystic fibrosis, in Poland. The company continues to seek therapies for the condition.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
AI Drone Project Launched to Detect Banana Disease in Davao Region
just now
Chinese Engineers Develop Triple System for Venus Atmosphere Analysis
32m ago
Artemis II Mission Preparations Intensify, Revealing Astronauts, Partners, and Spacesuit Details
33m ago
Neanderthal Diet in Lower Saxony Included Elephant, Bear, and Beaver
34m ago